RxDoctor Payments Data

Ashley Gentner

Family · Parkersburg, WVNPI 1912451287

Payments from drug & device makers

$5,678in general payments, 2019–2025

Across 375 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$970
  • Otsuka America Pharmaceutical, Inc.$781
  • Takeda Pharmaceuticals U.S.A., Inc.$601
  • Alkermes, Inc.$421
  • Lundbeck LLC$376
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$5,678100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,678 in reported general payments places this provider in the 90th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Medicare billing

Part B allowed, 2024
$27,516
Medicare patients
54
Services billed
375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl48$82,337
Risperdal ConstaRisperidone Microspheres18$31,407
TrintellixVortioxetine Hydrobromide16$14,180
Buspirone Hcl121$2,491
Bupropion XlBupropion Hcl101$2,435
Lurasidone Hcl14$1,837
Atomoxetine Hcl22$1,333
Lamotrigine86$1,108
Aripiprazole16$1,059
Ziprasidone Hcl17$1,057
Olanzapine20$827
Fluoxetine Hcl72$722
Duloxetine Hcl40$694
Quetiapine Fumarate26$510
Desvenlafaxine Succinate ErDesvenlafaxine Succinate14$469

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,447$82,33748 claims
Johnson & JohnsonRisperdal Consta$113$31,40718 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$601$14,18016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,507 family providers in West Virginia.

Other family in Parkersburg

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →